ANEST IWATA Corp. (6381) AI Stock Analysis

• Market Cap: ¥68.69B
• Dividend Yield: 3.95%
• Average Volume (3M): 80.39K
• Price to Earnings (P/E): 16.9
• Beta (1Y): 0.66
• Revenue Growth: -1.67%
• EPS Growth: -4.39%
• Country: JP
• Employees: 1,865
• Sector: Industrials
• Sector Strength: 72
• Industry: Industrial - Machinery
• EPS (TTM): 30.87
• Shares Outstanding: 41,745,502
• 10 Day Avg. Volume: 57,960
• 30 Day Avg. Volume: 80,393
• PEG Ratio: -0.92
• Price to Book (P/B): 0.96
• Price to Sales (P/S): 0.83
• P/FCF Ratio: 6.37
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 75 Outperform
• Price Target: ¥1,942.00 ▲(18.85% Upside)
• Action: Reiterated Date: 10/29/25
• Date: Action: Reiterated 10/29/25

ANEST IWATA Corp. demonstrates strong financial performance with solid revenue growth and profitability, supported by a robust balance sheet. While technical indicators suggest some short-term weakness, the stock's valuation remains attractive with a reasonable P/E ratio and a good dividend yield. The absence of recent earnings call data and corporate events does not impact the overall assessment.

Positive Factors

Balance Sheet Strength

Extremely low leverage and a high equity ratio provide durable financial flexibility. This capital structure reduces insolvency risk, lowers interest sensitivity, and supports sustained investment in R&D, capex, dividends or bolt-on M&A during industry downturns.

Cash Generation

Strong free cash flow growth and high cash conversion rates indicate the business reliably converts earnings to cash. That improves ability to fund capex, service operations, and return capital to shareholders without relying on external financing, strengthening long-term resilience.

Margin Sustainability

High gross margins and solid EBIT/EBITDA margins point to durable product-level profitability and operational efficiency. Such margins support reinvestment and buffer against pricing or input cost pressure, preserving earnings quality across cycles.

Negative Factors

Earnings Decline

Material negative EPS growth suggests recent pressure on bottom-line performance or one-off impacts. Persistent EPS declines can erode retained earnings, limit reinvestment capacity, and signal operational or demand weaknesses that may persist absent corrective action.

Modest Revenue Growth

Single-digit top-line growth indicates limited organic expansion and potential market saturation. Slow revenue growth constrains the company’s ability to scale fixed-cost leverage, limits margin expansion opportunities, and increases reliance on aftermarket or pricing rather than volume gains.

Cyclicality Exposure

Concentration in industrial and manufacturing end markets leaves revenue exposed to capex cycles and production slowdowns. Structural cyclicality can cause multi-quarter demand swings, complicating capacity planning and making long-term revenue visibility and investment timing challenging.

ANEST IWATA Corp. Business Overview & Revenue Model

Company Description

ANEST IWATA Corporation engages in the air energy and coating businesses in Japan and internationally. The company offers air compressors and nitrogen gas generators for various applications, such as factories, food production, hospitals, electric buses and new transportation systems, etc.; oil-free scroll vacuum pumps used in general industries, semiconductor manufacturing, food production, accelerators and synchrotron radiation facilities, etc.; steam power generators; spray guns, electrostatic coating machines, and paint supply equipment for industrial coating and automotive refinishing markets; and automatic painting devices, painting plants, painting robots, environmental devices, and painting booths. It also provides adhesive machinery, equipment, and systems; medical equipment; power supply units and power transmission devices. In addition, the company engages in the generation and sale of power derived from natural renewable energy. ANEST IWATA Corporation was founded in 1926 and is headquartered in Yokohama, Japan.

How the Company Makes Money

ANEST IWATA generates revenue through the sale of its extensive product lineup, which includes spray equipment, pumps, and compressors. The company benefits from a diversified customer base across multiple sectors, including automotive and industrial manufacturing. Key revenue streams include direct sales of products, aftermarket services, and maintenance contracts. Additionally, ANEST IWATA has established partnerships with various distributors and manufacturers, which help to expand its market reach and drive sales. The company's commitment to innovation and quality also contributes to customer loyalty and repeat business, further enhancing its revenue potential.

ANEST IWATA Corp. Financial Statement Overview

Summary

ANEST IWATA Corp. exhibits solid financial health with strong revenue growth, profitability, and cash flow generation. The company is well-positioned with a strong balance sheet characterized by low leverage and a high equity ratio, reducing financial risk. Continued focus on efficient operations and cash flow management will further enhance its financial strength.

Income Statement

ANEST IWATA Corp. shows a strong gross profit margin of 46.54% for the most recent year. The net profit margin for the same period is 7.86%, indicating effective cost control. Revenue growth has been consistent, with a 1.85% increase from the previous year. EBIT and EBITDA margins are solid at 10.85% and 18.13%, respectively, highlighting efficient operations and strong earnings before interest, tax, depreciation, and amortization.

Balance Sheet

The company maintains a low debt-to-equity ratio of 0.06, implying low financial leverage and risk. The return on equity stands at 9.13%, reflecting good profitability relative to equity. An equity ratio of 67.70% indicates a strong capital structure, with significant equity financing supporting overall financial stability.

Cash Flow

ANEST IWATA Corp. reports a robust free cash flow growth rate of 53.83% year-over-year, demonstrating efficient cash generation. An operating cash flow to net income ratio of 2.28 signifies strong cash flow from operations relative to net income. The free cash flow to net income ratio is 1.66, indicating healthy cash flow available after capital expenditures.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	54.02B	54.41B	53.42B	48.52B	42.34B	35.59B
Gross Profit	25.43B	25.32B	24.48B	21.34B	18.23B	14.93B
EBITDA	10.01B	9.86B	10.31B	9.23B	7.36B	5.83B
Net Income	4.12B	4.28B	4.93B	4.38B	3.54B	2.62B
Balance Sheet
Total Assets	67.14B	69.20B	66.14B	60.14B	55.82B	49.46B
Cash, Cash Equivalents and Short-Term Investments	18.84B	21.34B	16.93B	14.51B	14.32B	13.20B
Total Debt	2.78B	2.87B	3.07B	2.67B	2.42B	2.47B
Total Liabilities	15.13B	15.64B	16.07B	14.88B	15.61B	13.32B
Stockholders Equity	45.95B	46.85B	44.16B	40.03B	35.62B	32.24B
Cash Flow
Free Cash Flow	0.00	7.08B	4.60B	2.16B	2.45B	3.84B
Operating Cash Flow	0.00	9.75B	6.77B	4.33B	3.89B	4.60B
Investing Cash Flow	0.00	-3.25B	-1.26B	-3.32B	-1.08B	-1.07B
Financing Cash Flow	0.00	-3.93B	-3.58B	-2.36B	-2.10B	-1.96B

ANEST IWATA Corp. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1634.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6381, the sentiment is Neutral. The current price of 1634 is below the 20-day moving average (MA) of 1748.10, below the 50-day MA of 1698.54, and above the 200-day MA of 1543.77, indicating a neutral trend. The MACD of 15.71 indicates Positive momentum. The RSI at 49.34 is Neutral, neither overbought nor oversold. The STOCH value of 39.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:6381.

ANEST IWATA Corp. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6364	84 Outperform	¥64.25B	11.68	―	3.18%	2.98%	10.15%
6517	78 Outperform	¥75.79B	15.50	―	2.63%	-6.00%	-13.74%
6237	76 Outperform	¥62.19B	14.88	―	2.79%	2.85%	3.17%
6381	75 Outperform	¥68.69B	16.94	―	3.95%	-1.67%	-4.39%
6333	72 Outperform	¥49.59B	12.42	―	3.95%	1.72%	101.76%
6363	70 Outperform	¥70.88B	14.83	―	3.09%	6.35%	-34.20%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%

ANEST IWATA Corp. Corporate Events

ANEST IWATA Holds FY2025 Outlook Steady Despite Profit Decline in Q3

ANEST IWATA reported consolidated net sales of ¥39.49 billion for the third quarter of FY2025, down 1.3% year on year, with operating profit falling 18.1% to ¥3.80 billion as lower sales and higher selling and administrative expenses weighed on earnings. The air energy and coating segments both saw declines in revenue and profit despite signs of recovery in Chinese air compressors and spray gun demand, while other businesses grew via e-commerce but remained loss-making due to upfront investment; even so, the company kept its full-year earnings and dividend forecasts unchanged, signaling a focus on recovery through sales promotion measures.

Ordinary profit and net income also declined, despite positive contributions from foreign exchange gains and equity in earnings of affiliates, underscoring pressure on the core business. The decision to maintain guidance and dividends, coupled with continued investment in new businesses, suggests ANEST IWATA is prioritizing medium-term growth and market positioning over short-term margin protection, a stance that will be closely watched by shareholders exposed to cyclical demand in industrial equipment and coatings markets.

The most recent analyst rating on (JP:6381) stock is a Buy with a Yen1936.00 price target. To see the full list of analyst forecasts on ANEST IWATA Corp. stock, see the JP:6381 Stock Forecast page.

ANEST IWATA Posts Lower Q3 Profit but Boosts Dividend as Full-Year Outlook Held

ANEST IWATA reported FY2025 third-quarter consolidated net sales of ¥39.5 billion, down 1.3% year on year, with operating profit falling 18.1% to ¥3.8 billion and profit attributable to owners of parent slipping 5.6% to ¥3.4 billion, indicating margin pressure despite relatively stable revenue. The company’s financial position remained solid with an equity ratio of 68.0%, and it maintained its full-year forecast of ¥58.0 billion in sales and a 3.0% decline in profit, while significantly increasing annual dividends to a projected ¥83 per share, signaling continued shareholder-return emphasis even amid softer earnings.

For the full year ending March 31, 2026, ANEST IWATA expects 6.6% growth in net sales but anticipates declines in operating and ordinary profit of 6.0% and in net profit of 3.0%, underscoring concerns about profitability as costs and market conditions weigh on margins. The dividend hike from ¥45 in the previous fiscal year to a forecast ¥83 suggests management’s confidence in cash-flow resilience and a commitment to rewarding shareholders, even as earnings growth moderates and comprehensive income softens.

The most recent analyst rating on (JP:6381) stock is a Buy with a Yen1936.00 price target. To see the full list of analyst forecasts on ANEST IWATA Corp. stock, see the JP:6381 Stock Forecast page.